| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2001275018AAU2001275018B2 (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
| AU7501801AAU7501801A (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
| IL15368701AIL153687A0 (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
| CA002415225ACA2415225A1 (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
| EP01941684AEP1392346A4 (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
| NZ523403ANZ523403A (en) | 2000-05-30 | 2001-05-30 | Compounds that increase tissue elasticity and turgor which are analogous to portions of elastin |
| NO20030454ANO20030454L (en) | 2000-05-30 | 2003-01-29 | Composition and method of enhancing tissue elasticity |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/580,156 | 2000-05-30 | ||
| US09/580,893 | 2000-05-30 | ||
| US09/580,893US6794362B1 (en) | 2000-05-30 | 2000-05-30 | Asparagine containing elastin peptide analogs |
| US09/584,001 | 2000-05-30 | ||
| US09/584,001US6506731B1 (en) | 1998-03-13 | 2000-05-30 | Elastin peptide analogs and methods of using same |
| US09/580,110US6809075B1 (en) | 2000-05-30 | 2000-05-30 | Elastin peptide analogs and uses of same incombination with skin enhancing agents |
| US09/580,156US6962904B1 (en) | 1998-03-13 | 2000-05-30 | Elastin peptide analogs and uses thereof |
| US09/580,110 | 2000-05-30 |
| Publication Number | Publication Date |
|---|---|
| WO2001091700A2 WO2001091700A2 (en) | 2001-12-06 |
| WO2001091700A8true WO2001091700A8 (en) | 2003-11-20 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/017384WO2001091700A2 (en) | 2000-05-30 | 2001-05-30 | Composition and method for enhancing elasticity of tissue |
| Country | Link |
|---|---|
| EP (1) | EP1392346A4 (en) |
| AU (2) | AU2001275018B2 (en) |
| CA (1) | CA2415225A1 (en) |
| IL (1) | IL153687A0 (en) |
| NO (1) | NO20030454L (en) |
| NZ (1) | NZ523403A (en) |
| WO (1) | WO2001091700A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2827170B1 (en)* | 2001-07-13 | 2004-07-16 | Soc Extraction Principes Actif | USE OF PEPTIDES TO INCREASE CELL ADHESION |
| AU2002340202A1 (en)* | 2001-10-05 | 2003-06-17 | Procyte Corporation | Methods for the treatment of hyperpigmentation of skin |
| WO2003030860A1 (en)* | 2001-10-05 | 2003-04-17 | Procyte Corporation | Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
| US20040138103A1 (en)* | 2002-11-07 | 2004-07-15 | Procyte Corporation | Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto |
| DE10260928A1 (en)* | 2002-12-20 | 2004-07-08 | Henkel Kgaa | Method for the determination of markers of human facial skin |
| US6927205B2 (en) | 2003-04-28 | 2005-08-09 | Procyte Corporation | Compositions and methods for treatment of psoriasis |
| FR2854897B1 (en)* | 2003-05-12 | 2007-05-04 | Sederma Sa | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS FOR REDUCING THE SIGNS OF SKIN AGING. |
| EP1765280A1 (en)* | 2004-06-28 | 2007-03-28 | Procyte Corporation | Methods and compositions for preventing and treating hyperpigmentation of skin |
| US20090111758A1 (en) | 2006-05-15 | 2009-04-30 | Valio Ltd. | Use of therapeutically useful peptides |
| WO2008100789A2 (en) | 2007-02-16 | 2008-08-21 | Benaroya Research Institute At Virginia Mason | Compositions and methods for altering elastogenesis |
| ES2673672T3 (en) | 2011-02-11 | 2018-06-25 | The Regents Of The University Of Michigan | Tripeptide compositions and their use for the treatment of diabetes |
| WO2012135651A1 (en) | 2011-03-31 | 2012-10-04 | The Procter & Gamble Company | Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis |
| MX2014014898A (en) | 2012-06-06 | 2015-03-04 | Procter & Gamble | Systems and methods for identifying cosmetic agents for hair/scalp care compositions. |
| WO2021075707A1 (en) | 2019-10-16 | 2021-04-22 | 주식회사 네이처센스 | Peptide for improving memory and preventing or alleviating cognitive impairment, composition containing same and preparation method therefor |
| FR3116273B1 (en)* | 2020-11-17 | 2023-10-27 | Sederma Sa | Tetrapeptides, compositions comprising them and their cosmetic use |
| KR102484277B1 (en)* | 2021-11-22 | 2023-01-04 | 대한켐텍 주식회사 | Manufacturing Method Of Raw Material Composition For Improving Skin Beauty |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877805A (en)* | 1985-07-26 | 1989-10-31 | Kligman Albert M | Methods for treatment of sundamaged human skin with retinoids |
| DE19715103A1 (en)* | 1997-04-11 | 1998-10-15 | Targor Gmbh | Metallocene amino acid and peptide complexes |
| AU7103198A (en)* | 1997-04-21 | 1998-11-13 | Schering Corporation | Mammalian cytokines; related reagents and methods |
| US6069129A (en)* | 1998-03-13 | 2000-05-30 | Mrs, Llc | Elastin derived composition and method of using same |
| WO2000028996A1 (en)* | 1998-11-19 | 2000-05-25 | Mrs, Llc | Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides |
| CN1796404A (en)* | 1999-10-29 | 2006-07-05 | 启龙有限公司 | Neisserial antigenic peptides |
| Publication number | Publication date |
|---|---|
| EP1392346A2 (en) | 2004-03-03 |
| NZ523403A (en) | 2005-04-29 |
| CA2415225A1 (en) | 2001-12-06 |
| AU7501801A (en) | 2001-12-11 |
| WO2001091700A2 (en) | 2001-12-06 |
| NO20030454D0 (en) | 2003-01-29 |
| AU2001275018B2 (en) | 2008-04-03 |
| IL153687A0 (en) | 2003-07-06 |
| EP1392346A4 (en) | 2006-10-25 |
| NO20030454L (en) | 2003-01-29 |
| Publication | Publication Date | Title |
|---|---|---|
| EP1157707B8 (en) | Method and composition for deforming soft tissues | |
| AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
| AU2001249967A1 (en) | Composition and methods for tissue preservation | |
| AUPR638101A0 (en) | Composition and method for treatment of disease | |
| AU2002241228A1 (en) | Method and composition for treatment of skeletal dysplasias | |
| AU2001270943A1 (en) | Surgical instrument and method of using the same | |
| AU2001271530A1 (en) | Method of hard tissue repair | |
| AU2001233081A1 (en) | Composition for treatment of stress | |
| AU2001281140A1 (en) | Anti-plasmodium compositions and methods of use | |
| WO2001091700A8 (en) | Composition and method for enhancing elasticity of tissue | |
| AU2001271031A1 (en) | Cosmetic compositions for reducing and method of using the same | |
| AU5800399A (en) | Polish composition and method of use | |
| AU2001274181A1 (en) | Composition and method for biocide treatment of surfaces | |
| AU2001286983A1 (en) | Method of treatment | |
| AU2001233932A1 (en) | Method and composition | |
| AU2962400A (en) | Cleaner composition and method of use thereof | |
| AU2001234831A1 (en) | Magnetoliposome composition for targeted treatment of biological tissue and associated methods | |
| AU2001288291A1 (en) | Paving and sealing composition and method of use | |
| AU2003282593A1 (en) | Polyphenolamine composition and method of use | |
| AU4839100A (en) | Methods of using and compositions comprising n-desmethylzolpidem | |
| AU2001262177A1 (en) | Method of treatment | |
| AU2001253469A1 (en) | Compositions and methods for stabilizing modified tissue | |
| HK1063738A (en) | Composition and method for enhancing elasticity of tissue | |
| AU2001249194A1 (en) | Immunokine composition and method | |
| AUPQ876400A0 (en) | Compositions and method of using them |
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states | Kind code of ref document:A2 Designated state(s):AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW | |
| AL | Designated countries for regional patents | Kind code of ref document:A2 Designated state(s):GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG | |
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code | Ref country code:DE Ref legal event code:8642 | |
| WWE | Wipo information: entry into national phase | Ref document number:153687 Country of ref document:IL | |
| WWE | Wipo information: entry into national phase | Ref document number:2001941684 Country of ref document:EP | |
| WWE | Wipo information: entry into national phase | Ref document number:2001275018 Country of ref document:AU | |
| WWE | Wipo information: entry into national phase | Ref document number:523403 Country of ref document:NZ | |
| WWE | Wipo information: entry into national phase | Ref document number:2415225 Country of ref document:CA | |
| D17 | Declaration under article 17(2)a | ||
| WWP | Wipo information: published in national office | Ref document number:2001941684 Country of ref document:EP | |
| NENP | Non-entry into the national phase | Ref country code:JP | |
| WWP | Wipo information: published in national office | Ref document number:523403 Country of ref document:NZ | |
| WWG | Wipo information: grant in national office | Ref document number:523403 Country of ref document:NZ |